Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonist.

Slager RE, Otulana BA, Hawkins GA, Yen YP, Peters SP, Wenzel SE, Meyers DA, Bleecker ER.

J Allergy Clin Immunol. 2012 Aug;130(2):516-22.e4. doi: 10.1016/j.jaci.2012.03.030. Epub 2012 Apr 26.

2.

Pitrakinra for asthma.

Antoniu SA, Cojocaru I.

Expert Opin Biol Ther. 2010 Nov;10(11):1609-15. doi: 10.1517/14712598.2010.524203. Epub 2010 Oct 5. Review.

PMID:
20923253
3.

Cytokines or their antagonists for the treatment of asthma.

O'Byrne PM.

Chest. 2006 Jul;130(1):244-50. Review.

PMID:
16840409
4.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
5.

Emerging interleukin receptor antagonists for the treatment of asthma.

Al Efraij K, FitzGerald JM.

Expert Opin Emerg Drugs. 2017 Sep;22(3):275-283. doi: 10.1080/14728214.2017.1369954. Epub 2017 Aug 23. Review.

PMID:
28832218
6.

Pharmacogenetic tests in asthma therapy.

Yu IW, Bukaveckas BL.

Clin Lab Med. 2008 Dec;28(4):645-65. doi: 10.1016/j.cll.2008.05.001. Review.

PMID:
19059068
7.

Monoclonal antibodies for the treatment of refractory asthma.

Hambly N, Nair P.

Curr Opin Pulm Med. 2014 Jan;20(1):87-94. doi: 10.1097/MCP.0000000000000007. Review.

PMID:
24275927
8.

Dupilumab for the treatment of asthma.

Santini G, Mores N, Malerba M, Mondino C, Anzivino R, Macis G, Montuschi P.

Expert Opin Investig Drugs. 2017 Mar;26(3):357-366. doi: 10.1080/13543784.2017.1282458. Epub 2017 Feb 7. Review.

PMID:
28085503
9.

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.

Kew KM, Karner C, Mindus SM, Ferrara G.

Cochrane Database Syst Rev. 2013 Dec 16;(12):CD009019. doi: 10.1002/14651858.CD009019.pub2. Review.

PMID:
24343671
10.

Spotlight on montelukast in asthma in children 2 to 14 years of age.

Muijsers RB, Noble S.

Am J Respir Med. 2002;1(3):225-8. Review.

PMID:
14720060
11.

A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.

Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica GW.

Int Arch Allergy Immunol. 2016;170(2):122-31. doi: 10.1159/000447692. Epub 2016 Aug 3. Review.

Supplemental Content

Support Center